Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B

Basit Öğe Kaydı
dc.contributor.authorChan, Henry Lik Yuen
dc.contributor.authorLim, Young-Suk
dc.contributor.authorSeto, Wai Kay Walter
dc.contributor.authorAgarwal, Kosh
dc.contributor.authorBrunetto, Maurizia R.
dc.contributor.authorJanssen, Harry L. A.
dc.contributor.authorCaruntu, Florin
dc.date.accessioned2024-04-24T17:50:01Z
dc.date.available2024-04-24T17:50:01Z
dc.date.issued2018
dc.departmentDicle Üniversitesien_US
dc.descriptionAnnual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting -- NOV 09-13, 2018 -- San Francisco, CAen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Assoc Study Liver Disen_US
dc.identifier.endpage228Aen_US
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.startpage227Aen_US
dc.identifier.urihttps://hdl.handle.net/11468/23162
dc.identifier.volume68en_US
dc.identifier.wosWOS:000446020500384
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofHepatology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleThree Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis Ben_US
dc.titleThree Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu